ERBB2 and breast cancer: Conversely, HER2-low BC was less likely to express histological Grade 3 than both HER2-zero (35.5% vs. 55.6%, p < 0.001) and HER2-positive (35.5% vs. 57.4%, p < 0.001) [9].